Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0461929603
Thu, 17.08.2023
Xlife Sciences AG
Abu Dhabi, United Arab Emirates, 16th of August 2023: Xlife Sciences AG (SIX: XLS) signed a Memorandum of Understanding (MoU) with the regulator of the healthcare sector in the Emirate Abu Dhabi, the Department of Health – Abu Dhabi (DoH). This signed agreement, formalized at the Department's central headquarters, aims to directly enhance patient e [ … ]
Tue, 20.06.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): AGMEGM
Media Release
Zurich, June 20, 2023
Xlife Sciences: shareholders approved all motions at today’s AGM 2023
20.06.2023 / 17:00 CET/CEST
Xlife Sciences AG (SIX: XLS) announces that its shareholders approved all motions on the agenda of the Ordinary Annual General Meeting (AGM) 2023 that [ … ]
Tue, 20.06.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): AGMEGM
Media Release
Zurich, June 20, 2023
Xlife Sciences: shareholders approved all motions at today’s AGM 2023
20.06.2023 / 17:00 CET/CEST
Xlife Sciences AG (SIX: XLS) announces that its shareholders approved all motions on the agenda of the Ordinary Annual General Meeting (AGM) 2023 that [ … ]
Fri, 26.05.2023
Xlife Sciences AG
Xlife Sciences AG (SIX: XLS) today published the agenda of its upcoming Ordinary Annual General Meeting 2023 that will take place on Tuesday, June 20, as of 10 am CET at Hotel “Schweizerhof” in Zurich, Switzerland:
The voting items for the Annual General Meeting 2023 include, among others, the approval of the annual financial statements and the co [ … ]
Fri, 26.05.2023
Xlife Sciences AG
Xlife Sciences AG (SIX: XLS) today published the agenda of its upcoming Ordinary Annual General Meeting 2023 that will take place on Tuesday, June 20, as of 10 am CET at Hotel “Schweizerhof” in Zurich, Switzerland:
The voting items for the Annual General Meeting 2023 include, among others, the approval of the annual financial statements and the co [ … ]
Thu, 27.04.2023
Xlife Sciences AG
Xlife Sciences AG (SIX: XLS) today published the full Valuation Report 2022, which values the company's portfolio as of the end of 2022. The valuation was carried out by the independent consultancy Cylad Experts and covers 20 of Xlife Sciences’ 26 project companies.[1] The valuation is primarily based on the risk-adjusted net present value (NPV), t [ … ]
Thu, 27.04.2023
Xlife Sciences AG
Xlife Sciences AG (SIX: XLS) today published the full Valuation Report 2022, which values the company's portfolio as of the end of 2022. The valuation was carried out by the independent consultancy Cylad Experts and covers 20 of Xlife Sciences’ 26 project companies.[1] The valuation is primarily based on the risk-adjusted net present value (NPV), t [ … ]
Thu, 20.04.2023
Xlife Sciences AG
Xlife Sciences AG (SIX: XLS) today reported its 2022 results and 2023 outlook. The company also published the independent valuation report covering its project portfolio as of December 31, 2022.
Operational progress in 2022
As at December 31, 2022, Xlife Sciences had 26 project companies. Among other things, they made the following pleasing progre [ … ]
Thu, 20.04.2023
Xlife Sciences AG
Xlife Sciences AG (SIX: XLS) today reported its 2022 results and 2023 outlook. The company also published the independent valuation report covering its project portfolio as of December 31, 2022.
Operational progress in 2022
As at December 31, 2022, Xlife Sciences had 26 project companies. Among other things, they made the following pleasing progre [ … ]
Thu, 16.02.2023
Xlife Sciences AG
Medical Screening Device Set to Measure Complex Neurocognitive Performance for Early Detection of Severe Neurodegenerative Diseases Such as Parkinson's or Alzheimer's
saniva diagnostics, a portfolio company of Xlife Sciences (SIX: XLS), has received the 513(g) approval from the US Food and Drug Administration (FDA) to market and sell its proprietar [ … ]